Trading Ideas Genmab A/S London S.E.

Equities

0MGB

DK0010272202

Market Closed - London S.E. Other stock markets 15:55:00 05/07/2024 BST			5-day change	1st Jan Change
1,760 ^DKK	+1.84%		-0.05%	-17.83%

06-28	Would you like some more inflation?
06-28	Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU	MT

Trading Ideas

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

GENMAB A/S :The comeback of an upward trend can be anticipated	03-11
GENMAB A/S :Expectation of a turn-around	01-25
GENMAB A/S :Expectation of a turn-around	01-04
GENMAB A/S :The comeback of an upward trend can be anticipated	12-08
GENMAB A/S :Technically solid	16/11/22
GENMAB A/S :Buyers are coming back	12/08/22
GENMAB A/S :Comeback of a rising trend?	31/03/22
GENMAB A/S :The underlying trend is to the upside	15/06/20
GENMAB A/S :The underlying trend is to the upside	31/01/20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Genmab: A good start to 2024; guidance unchanged

GENMAB : A good start to 2024; guidance unchanged

May 03, 2024 at 06:08 pm

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Secure my Investments

fermer